Publications by authors named "R J Diebold"

Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease that leads to respiratory decline caused by scarring and thickening of lung tissues. Multiple pathways contribute to the fibrotic process in this disease, such as inflammation, epithelial-to-mesenchymal transition, and oxidative stress. The Rho-associated coiled-coil forming protein kinase (ROCK) signaling pathway is a key regulator of profibrotic signaling, as it affects the organization of actin-myosin and the remodeling of the extracellular matrix.

View Article and Find Full Text PDF

Background: There is a growing demand for quality osteoarthritis management available in Australia. There has been increasing emphasis on post-total knee replacement pain relief as a significant issue, especially in the context of postoperative recovery protocols which focus on early mobility.

Methods: The aim of this study was to assess if the addition of adductor canal blocks (ACB) reduced postoperative pain and affected mobility post primary total knee arthroplasty (TKR) at Armidale Rural Referral Hospital (ARRH).

View Article and Find Full Text PDF

Purpose: The main objective of this open, prospective, multicentre, observational study is to investigate the relapse rate and tolerability of lactic acid gels in adult female patients with recurrent urinary tract infections during routine practice.

Methods: Data were collected from patients undergoing intermittent short courses of intravaginal treatment with lactic acid gel for prevention of recurrent urinary tract infections. The observation period for individual patients was 4 months, aimed at covering four short courses of intravaginal treatment.

View Article and Find Full Text PDF
Article Synopsis
  • Targeting Bcl-2 family proteins is vital for cancer treatment, prompting the development of AZD4320, a dual inhibitor that effectively addresses resistance mechanisms, particularly from Bcl-x.
  • Through structure-based chemistry, AZD4320 was designed to bind strongly to Bcl-2 and Bcl-x, leading to enhanced apoptosis in cancer cells, especially in acute myeloid leukemia (AML).
  • Initial results show that AZD4320 can shrink tumors while temporarily lowering platelet counts, which recovers quickly, indicating its promise as a weekly treatment option across various cancers linked to Bcl-2 dysregulation.
View Article and Find Full Text PDF